Clinical trial
Diuretic Treatment in High Risk Decompensated Advanced Heart Failure. Bolus Intermittent Versus Continuous Infusion of Furosemide: a Randomized Controlled Trial.
NCT03592836 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diuretic Treatment in High Risk Decompensated Advanced Heart Failure. Bolus Intermittent Versus Continuous Infusion of Furosemide: a Randomized Controlled Trial.
- Lead sponsor
- University of Turin, Italy
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 1, 2013
- Completion date
- December 22, 2017
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure nyha class iii, heart failure nyha class iv